Abaxis (ABAX)

44.22 -0.45  -1.01%  May 21, 8:00PM
Add to Watchlists Create an Alert
View Full Chart
ABAX Price Chart
    View All Performance Charts

    ABAX Total Returns Comparison

    This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Abaxis is up 38.30% over the last year vs S&P 500 Total Return up 31.95%, Alere up 42.55%, and Meridian Bioscience up 18.66%.

    ABAX Fundamentals

    Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

    Income Statement View Statement

    Balance Sheet View Statement

    Get Quote for

    Pro Report PDF for ABAX

    Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

    Download ABAX Pro Report PDF

    Pro Strategies Featuring ABAX

    Did Abaxis make it into our Pro Portfolio Strategies?

    Start your YCharts Pro membership now to find out.

    ABAX Profile

    Exchange: NASDAQ
    Sector: Healthcare
    Industry: Diagnostics & Research

    Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in veterinary or human patient-care setting to provide blood constituent measurements for clinicians worldwide. The company offers point-of-care blood chemistry analyzer to perform 14 tests on human patients and 13 tests on veterinary patients. It markets the blood analysis system under the Piccolo Xpress and Piccolo Classic names in the medical market; and under the VetScan VS2 and VetScan Classic names in the veterinary market. The company also provides reagent discs to handle various technical steps of blood chemistry testing; and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments for veterinary applications. In addition, its products include VetScan VSpro, which assists in the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, evaluation of disseminated intravascular coagulation, hepatic disease, monitoring therapy, and the progression of disease states. Further, the company offers VetScan VSpro fibrinogen test to provide in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; and VetScan i-STAT 1 that delivers blood gas, electrolyte, basic blood chemistry, and hematology results. Additionally, its products comprise VetScan Canine heartworm rapid test to detect dirofilaria immitis in canine whole blood, serum, or plasma; VetScan Canine parvovirus rapid test kit to detect canine parvovirus antigen in feces; VetScan Giardia rapid test to detect giardiasis, a gastrointestinal infection caused by the protozoan parasite Giardia; and Orbos Discrete Lyophilization process that involves in flash-freezing a drop of liquid reagent to form a solid bead and then freeze-drying the bead to remove water. Abaxis sells its products through direct sales force and independent distributors. The company was founded in 1989 and is headquartered in Union City, California.

    Recent Quotes

    Symbol Price Chg Chg % Market Cap
    ABAX 44.22 -0.45 -1.01% 976.02M
    New watchlist
    Create
    Success.

    Your new watchlist has been created

    View WatchlistsDone
    Create Watchlist from Quotes

    Register for your Free YCharts Account.

    Understand your investments with more data than any other free site.

    • Create watchlists that you care about for stocks or economic indicators
    • Create alerts to track the movements of your stocks
    • Access stock analysis from our in-house experts
    Get Started Now

    Already registered? Sign in to your account.

    document.write('');